XOSPATA Presentation
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients
PRESENTER
RSVP by 8/20/19 to Melba Vasquez
|
|
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients
PRESENTER
RSVP by 8/20/19 to Melba Vasquez
|
|